NCT06858787NARecruitingAccepts Healthy Volunteers

Validating CGM for GDM

Icahn School of Medicine at Mount Sinai

Start Date

10/2/2025

Completion Date

4/1/2028

Summary

This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice Associates) will be enrolled. Potential participants will be approached during their prenatal care appointments. Participants will complete an informed consent form for the study during their standard-of-care prenatal appointments at our institution.

Eligibility Criteria

Age Range: 18 years to 50 years

Inclusion Criteria: * Ages 18-50 * Singleton pregnancy between 24-32 weeks gestational age * Prenatal care and delivery at Mount Sinai Hospital Exclusion Criteria: * Multiple fetal gestation * Preexisting diabetes * Concurrent use of steroids * Anomalous fetus * Insufficient prenatal care (identified as missing half the recommended visits or establishing care after 20 weeks gestation) * Unable to tolerate oral glucose test

Interventions

DEVICE

Continuous glucose monitor

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Gestational Diabetes Mellitus (GDM)

Locations

Icahn School of Medicine at Mount Sinai

New York, New York 10029

United States

Mount Sinai South Nassau

Oceanside, New York 11572

United States